Theralase Technologies Inc. (TSXV:TLT)
Canada · Delayed Price · Currency is CAD 0.1800
+0.0050 (2.86%)
Aug 13, 2026, 10:58 AM EST
Theralase Technologies Market Cap
Theralase Technologies has a market cap or net worth of CAD 51.74 million as of August 13, 2026. Its market cap has decreased by -8.51% in one year.
Market Cap
51.74M
Enterprise Value
51.17M
Revenue
857.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.18
ChartMarket Cap Chart
Since April 2, 1996, Theralase Technologies's market cap has increased from 8.33M to 51.74M, an increase of 521.33%. That is a compound annual growth rate of 6.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 56.18M | 28.52% |
| Dec 31, 2025 | 43.71M | -33.43% |
| Dec 31, 2024 | 65.66M | 64.23% |
| Dec 28, 2023 | 39.98M | -42.29% |
| Dec 30, 2022 | 69.28M | -9.56% |
| Dec 31, 2021 | 76.60M | 97.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Profound Medical | 374.28M |
| Vector Science and Therapeutics | 250.18M |
| Cannabix Technologies | 68.79M |
| Perimeter Medical Imaging AI | 49.87M |
| Cheelcare | 31.48M |
| Conavi Medical | 20.18M |
| Ventripoint Diagnostics | 19.10M |
| MedX Health | 16.40M |